n.dziedzic
TL2 · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 28 May 2025 · last posted 6d
84 posts, newest first. Showing up to 150.
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #19 · Compounds › Semaglutide · 22 Jul 2026 · 8 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #120 · Evidence › Journal club · 20 Jul 2026 · 4 likes The arithmetic on SURMOUNT-OSA is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Comparing documentation quality across the directory, tabulated Replied, post #10 · Sourcing › Vendor reports · 14 Jul 2026 · 18 likes Taking post #7 at face value and following it one step further. Comparing documentation quality was covered in the wiki last year and the page has a review date on it,…
-
Micro-titration: a disputed topic, argued properly Replied, post #104 · Practice › Dosing & titration · 13 Jul 2026 · 1 like On micro-titration: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #27 · Clinical › Comorbidities · 11 Jul 2026 · 22 likes Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied. Happy to be the one who is wrong…
-
Journal club: LEADER as the historical anchor Replied, post #102 · Evidence › Journal club · 10 Jul 2026 · 1 like I had written a reply contradicting post #98 and deleted it. Here is what survived. Where the group cannot agree, record the disagreement rather than resolving it by…
-
How shortages have affected compounding permissions Replied, post #24 · Access › Shortages · 8 Jul 2026 · 24 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.…
-
Programming during a large energy deficit Replied, post #32 · Nutrition & Training › Resistance training · 5 Jul 2026 · 1 like That is clearer than the version I had in my head. Thank you.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #50 · Access › International · 2 Jul 2026 · 1 like Adding the measurement that post #47 says would settle it. Where a jurisdiction has published guidance for clinicians, that document usually answers the practical…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #51 · Clinical › Bloodwork · 2 Jul 2026 · 19 likes Filing a mild objection to the consensus on Liver enzymes drifting. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Revisiting: The best-written scientific paper you have read Replied, post #61 · Lounge › Off topic · 30 Jun 2026 · 16 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that. I…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #48 · Start Here › Welcome · 28 Jun 2026 · 17 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Injecting into an area that has become firm: why not to Replied, post #55 · Practice › Administration · 12 Jun 2026 · 1 like Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #41 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 28 likes Post #37 put the caveat in the right place and I want to underline it. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species'…
-
Why this subcategory is stricter about sourcing than most Replied, post #36 · Compounds › Secretagogues & GH axis · 30 May 2026 · 29 likes Published human data on most of this family is thin, old, or from small studies with surrogate endpoints. That is a genuine limitation and it is the honest answer to…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #17 · Start Here › Welcome · 29 May 2026 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #19 · Compounds › Oral incretins · 2 May 2026 · 0 likes Coming back to post #16, because the follow-up matters more than the original answer. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer…
-
Does a peptide degrade silently, with no visual change? Replied, post #16 · Practice › Storage & stability · 26 Apr 2026 · 8 likes Coming back to post #13, because the follow-up matters more than the original answer. Taking peptide seriously for a moment rather than deflecting: the honest position…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #47 · Sourcing › Logistics · 20 Apr 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #20 · Evidence › Journal club · 2 Apr 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #21 · Practice › Storage & stability · 24 Mar 2026 · 25 likes Post #20 describes the usual case. This is about the unusual one. Reporting rather than recommending, on adsorptive losses. What happened is above. Whether it should…
-
Grapefruit: why this class is not the class that cares Replied, post #67 · Practice › Interactions · 22 Mar 2026 · 0 likes Adding the boring version of grapefruit, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
-
Search filters: what is missing Replied, post #38 · Meta › Site feedback · 21 Mar 2026 · 0 likes Post #36 and I disagree about the size of the effect, not about the direction. Where I would push back on the search filters consensus is the confidence, not the…
-
Revisiting: Maintainer handover: how it works Replied, post #35 · Meta › Wiki maintenance · 7 Mar 2026 · 26 likes Maintainer handover is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Bioimpedance and hydration: why the number moves Replied, post #14 · Outcomes › Body composition · 5 Mar 2026 · 21 likes Worth separating two things that post #10 runs together. On bioimpedance and hydration: the maintained page in the documentation commons covers the general case with…
-
Grapefruit: why this class is not the class that cares Replied, post #5 · Practice › Interactions · 2 Mar 2026 · 32 likes On the opening post — agreed on the reasoning, with one qualification. Speaking only to grapefruit as I have actually seen it, rather than as it is usually described:…
-
The headache that turns out to be dehydration — the long version Started this topic · Nutrition & Training › Hydration & electrolytes · 12 Feb 2026 · 0 likes On the subject in the title: The headache that turns out to be dehydration — the long version Working notes rather than a conclusion. A narrow question about headache,…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #54 · Start Here › How to Ask · 19 Jan 2026 · 0 likes That reframing is the whole thing. The facts I already had.
-
What to include when your question involves a chromatogram Replied, post #55 · Start Here › How to Ask · 19 Jan 2026 · 23 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one. I…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #22 · Data & Tools › Calculators · 14 Jan 2026 · 4 likes Everything in post #18 holds. The case it does not cover is the one I have. The most common input error is entering the vial mass in the concentration field. It…
-
A partial dose because the pen emptied mid-injection Replied, post #104 · Practice › Administration · 10 Jan 2026 · 1 like Agreed, and I will stop repeating the version of this I had been repeating.
-
Reading an interaction checker output critically Replied, post #87 · Practice › Interactions · 8 Jan 2026 · 0 likes Picking up post #86: that is the part I would want checked first. Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #30 · Practice › Interactions · 8 Jan 2026 · 1 like No notes. Posting so the count is not one.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #9 · Clinical › Special populations · 7 Jan 2026 · 0 likes Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin enough that the honest answer is short.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #93 · Analytics › COA interpretation · 19 Dec 2025 · 12 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Prescription requirements and telehealth models Replied, post #64 · Sourcing › Regulatory · 13 Dec 2025 · 5 likes Post #61 answers the question as asked. The question underneath it is different. I would call the community position on prescription requirements and telehealth models…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #112 · Practice › Reconstitution · 3 Dec 2025 · 5 likes I read post #108 twice before replying, because I had assumed the opposite. The thing about decimal-point error that took me longest to accept is that a plausible…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #78 · Analytics › COA interpretation · 26 Nov 2025 · 6 likes On post #74 — agreed on the reasoning, with one qualification. An itemised related-substances table with retention times says considerably more about the synthesis than…
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Started this topic · Practice › Side effects · 20 Nov 2025 · 0 likes On the subject in the title: Injection-site reactions: describing them precisely enough to be useful Working notes rather than a conclusion. Reading back through what…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #62 · Compounds › Oral incretins · 16 Nov 2025 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #116 · Practice › Storage & stability · 2 Nov 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. For what it is worth, the same held on…
-
Reconciling a supplier certificate with an independent result Replied, post #18 · Sourcing › Vendor reports · 30 Oct 2025 · 7 likes Where I part company with post #14, and it is a narrow parting. Blind submission is worth the extra effort. Have someone else relabel the sample so neither you nor the…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #25 · Documentation › Doc review · 28 Oct 2025 · 1 like Post #23 and I disagree about the size of the effect, not about the direction. For anyone finding this later: the short answer on evidence digest is that it depends on…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #110 · Practice › Storage & stability · 25 Oct 2025 · 28 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The uncertainty…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #38 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Comparing my trajectory with the trial curves, carefully Replied, post #57 · Outcomes › Progress reports · 4 Oct 2025 · 15 likes Where I part company with post #53, and it is a narrow parting. Rate of change matters more than the absolute number for most of the questions people ask about their…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #124 · Evidence › Study critique · 16 Sep 2025 · 10 likes Coming back to post #120, because the follow-up matters more than the original answer. Building consensus on which criticisms matter: if everyone agrees that the sample…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #57 · Practice › Reconstitution · 10 Sep 2025 · 7 likes Good question, well framed, and I would like to see it answered properly.
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #73 · Devices › Cold chain · 7 Sep 2025 · 12 likes Recording arrival condition on ordinary deliveries is what makes the record useful. A file containing only the bad arrivals cannot tell you how often they happen. The…
-
Follow-up: Why appetite effects are mostly central Replied, post #30 · Pharmacology › Receptor biology · 1 Sep 2025 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #28 · Compounds › Tirzepatide · 28 Aug 2025 · 5 likes That is a fair summary of where the discussion has got to.
-
Asking about a compound your prescriber has not heard of Replied, post #133 · Clinical › Prescriber conversations · 21 Aug 2025 · 1 like If time runs out, asking what to do next — book again, phone, message — is better than leaving with unfinished business.
-
Hypertension improvement and when medication needs revisiting Replied, post #9 · Clinical › Comorbidities · 14 Aug 2025 · 0 likes The version of hypertension improvement that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #17 · Compounds › Secretagogues & GH axis · 31 Jul 2025 · 0 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Immortal time bias in a claims-database study Replied, post #7 · Evidence › Study critique · 26 Jul 2025 · 2 likes Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by default. Reporting both is the practice worth insisting on.
-
A preprint whose numbers changed substantially at publication Replied, post #3 · Evidence › Preprints · 26 Jul 2025 · 14 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
-
Why the timeline is on the right and not the left Replied, post #44 · Meta › Site feedback · 22 Jul 2025 · 33 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
A field-by-field walk through a certificate of analysis Replied, post #138 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes If you are new and reading this thread for the answer to field-by-field walk through a certificate: the answer is conditional, the conditions are in the third reply,…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #111 · Wellbeing › Mental health · 2 Jul 2025 · 23 likes Anxiety was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #30 · Access › Insurance & coverage · 30 Jun 2025 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Worth separating Reading a denial letter as a question about the compound from Reading a…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #14 · Sourcing › Red flags · 22 Jun 2025 · 0 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. Where the same certificate image appears with different lot…
-
Half-life, steady state, and accumulation worked through Replied, post #88 · Pharmacology › Pharmacokinetics · 9 Jun 2025 · 6 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Half-life, steady state, and accumulation worked through Replied, post #63 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 0 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
-
A claim built entirely on a subgroup analysis Replied, post #70 · Evidence › Study critique · 2 Jun 2025 · 7 likes Building on post #69 rather than restating it. The honest answer on claim built is that it depends, and the useful part is the list of what it depends on. Four items,…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #3 · Evidence › Trials · 28 May 2025 · 0 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Why plausible mechanism is not evidence of effect Replied, post #12 · Compounds › Repair & healing peptides · 27 May 2025 · 2 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Antibiotics and a course of something with delayed emptying Replied, post #42 · Practice › Interactions · 16 May 2025 · 1 like Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #32 · Clinical › Comorbidities · 12 May 2025 · 18 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Follow-up: What other technical communities get right that we do not Replied, post #85 · Lounge › Off topic · 2 May 2025 · 22 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. The short version is the first sentence; the rest is why.
-
Requesting a page: what makes a good request Replied, post #28 · Documentation › Wiki requests · 19 Mar 2025 · 0 likes A request that says what the page should not cover is unusually helpful, because scope creep is what kills these. A modest claim, modestly supported.
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Started this topic · Evidence › Journal club · 9 Mar 2025 · 0 likes On the subject in the title: Journal club: the retatrutide phase 2 obesity paper Working notes rather than a conclusion. A follow-up question about retatrutide phase 2…
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #12 · Compounds › Secretagogues & GH axis · 5 Feb 2025 · 0 likes On analysis: these are short peptides and generally straightforward chromatographically, which means a poor purity result is more likely to reflect the synthesis than…
-
Protein density versus volume when you cannot eat much Replied, post #4 · Nutrition & Training › Protein & intake · 22 Jan 2025 · 7 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake. I…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #125 · Compounds › Oral incretins · 28 Dec 2024 · 29 likes Adding the measurement that post #124 says would settle it. Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of…
-
Why "any advice?" is the least effective ending for a post Replied, post #84 · Start Here › How to Ask · 28 Nov 2024 · 5 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
What changed in 2026, by region Replied, post #2 · Access › International · 28 Nov 2024 · 0 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them. Written quickly, so…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #19 · Practice › Reconstitution · 19 Nov 2024 · 20 likes I would rather this thread reach "we do not know" about Choosing a concentration than reach a confident answer that nobody can support when asked.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #65 · Analytics › Method validation · 3 Nov 2024 · 2 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways. That is one dataset and I would…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #97 · Analytics › COA interpretation · 27 Oct 2024 · 4 likes This follows post #94 rather than contradicting it. What I want from this field-by-field walk through a certificate thread is the list of things that would need to be…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #43 · Compounds › Retatrutide · 17 Sep 2024 · 0 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Blind submission and why it changes minds Replied, post #55 · Sourcing › Independent verification · 7 Sep 2024 · 0 likes Trying to state the blind submission position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that…
-
About the Off topic category Replied, post #3 · Lounge › Off topic · 26 Aug 2024 · 30 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
How this community labels and discusses unrefereed work Replied, post #79 · Evidence › Preprints · 12 Jul 2024 · 16 likes Filing a mild objection to the consensus on community labels. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Why I ask for the gradient before I discuss the number Replied, post #4 · Analytics › HPLC & UHPLC · 28 Jun 2024 · 23 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Gradient delay volume differs between instruments and shifts the…